Thomas Shrader Profile - BTIG Analyst

235 Followers
tipranks
Thomas Shrader

Thomas Shrader
BTIG

Wall Street Analyst
#4,605 out of 10,123 Wall Street Analysts
#12,495 out of 42,330 experts

Success Rate

38%
183 out of 487 ratings made a profit

Average Return

+1.40%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Thomas Shrader's trades since 2015 and holding each position for 1 Year would result in 37.58% of your transactions generating a profit, with an average return of 1.4% per rating.

Stock Rating Distribution

831Ratings
86.88% Buy
13.12% Hold
0.00% Sell
Distribution of Thomas Shrader's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United States
Canada

Best Rating

Stock:
Verona Pharma
(VRNA)
Rating:Buy
Date:Jun 26, 2024 - Jun 26, 2025
Return:+542.60%
The most profitable rating made by Thomas Shrader

Thomas Shrader's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Gilead Sciences
Mar 23, 2015
Hold
Downgraded
1Ratings
0.00%
MRNS
Marinus
Jun 13, 2016
Hold
Downgraded
1Ratings
0.00%
MDVN
Medivation
Aug 23, 2016
Hold
Downgraded
3Ratings
0.00%
VTAE
Vitae Pharma
Sep 14, 2016
Hold
Downgraded
5Ratings
0.00%
MTEMQ
Molecular Templates
Nov 07, 2016
Hold
Reiterated
$4.40
3Ratings
0.00%
Eledon Pharmaceuticals
Dec 22, 2016
Hold
Reiterated
$10.80
(596.77% Upside)
4Ratings
0.00%
ARGSQ
Argos Therapeutics
May 11, 2017
Hold
Reiterated
6Ratings
0.00%
CLVSQ
Clovis Oncology
Jun 19, 2017
Buy
Reiterated
16Ratings
0.00%
FibroGen
Jun 21, 2017
Buy
Reiterated
$38.00
(344.44% Upside)
9Ratings
0.00%
Windtree Therapeutics
Jun 30, 2017
Hold
Downgraded
$6.00
(12144.90% Upside)
1Ratings
0.00%
List of latest recommendations made by Thomas Shrader. Click to expand and see Thomas Shrader's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Advertisement
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

About Analyst Ratings

About Analyst Ratings
Analyst ratings represent professional recommendations - Buy, Hold, or Sell - issued for a specific stock. Each rating reflects the analyst’s view at the time of publication and is tracked to measure historical performance.
Ratings Count
The total number of analyst ratings (Buy, Hold, and Sell) issued for the stock. This includes all published recommendations, even those not used in performance calculations.
Performance Calculation
To ensure accuracy and prevent duplication, only certain ratings are included in performance metrics:
•  
One rating per analyst per month: If an analyst publishes more than one rating in a month, only the first is counted.
•  
Updated ratings end prior ones: If the analyst changes their stance during that month (for example, from Buy to Sell), performance tracking for the earlier rating stops immediately on the update date, and the new rating begins tracking from that point forward.
•  
Hold ratings excluded: Hold recommendations are displayed on the chart but are not counted in performance or return calculations.
Example
If an analyst rates a stock Buy on April 1 and changes it to Sell on April 20, the Buy rating’s performance is measured from April 1 to April 20. From April 20 onward, only the Sell rating is tracked.
Success Rate
Indicates the percentage of performance-accounted ratings that generated a positive return during their active period. For example, if 6 out of 17 accounted ratings were profitable, the success rate is 35%.
Average Return
Represents the mean return per active rating - showing the average gain or loss an analyst’s recommendation produced while it was active.

Thomas Shrader activity FAQ

What is the performance of Thomas Shrader's recommendations?
The percentage of profitable recommendations made by Thomas Shrader is 38%, and the average return per transaction is 1.40%.
    What stocks does Thomas Shrader cover?
    Thomas Shrader mostly covers BIIB ,INMB ,DNLI stocks.
      What was Thomas Shrader's most profitable rating?
      Thomas Shrader’s most profitable ratings was a buy on VRNA stock on Jun 26, 2024 - Jun 26, 2025. The return on the trade was +542.60%.
        Where can I see a list of stock analyst ratings?
        You can see a list of daily stock analyst ratings here.
          What are the most recommended stocks by analysts?
          You can see a list of the most recommended stocks by analysts here